BRCA1 and glioblastoma: In our European population and during the last 10 years of BRCA1 mutation screening, approximately between 2 and 8 cases associating BRCA1 mutation and GBM for 100 million women are expected [24-26], but only three cases have been reported in the literature (two in Europe in the same centre and one in United States).